"Colorectal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Descriptor ID |
D015179
|
| MeSH Number(s) |
C04.588.274.476.411.307 C06.301.371.411.307 C06.405.249.411.307 C06.405.469.158.356 C06.405.469.491.307 C06.405.469.860.180
|
| Concept/Terms |
Colorectal Neoplasms- Colorectal Neoplasms
- Neoplasms, Colorectal
- Colorectal Neoplasm
- Neoplasm, Colorectal
- Colorectal Tumors
- Colorectal Tumor
- Tumor, Colorectal
- Tumors, Colorectal
Colorectal Carcinoma- Colorectal Carcinoma
- Carcinoma, Colorectal
- Carcinomas, Colorectal
- Colorectal Carcinomas
Colorectal Cancer- Colorectal Cancer
- Cancer, Colorectal
- Cancers, Colorectal
- Colorectal Cancers
|
Below are MeSH descriptors whose meaning is more general than "Colorectal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Colorectal Neoplasms".
This graph shows the total number of publications written about "Colorectal Neoplasms" by people in this website by year, and whether "Colorectal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 0 | 3 |
| 1996 | 3 | 1 | 4 |
| 1997 | 3 | 0 | 3 |
| 1998 | 8 | 1 | 9 |
| 1999 | 5 | 0 | 5 |
| 2000 | 7 | 3 | 10 |
| 2001 | 16 | 0 | 16 |
| 2002 | 15 | 2 | 17 |
| 2003 | 7 | 1 | 8 |
| 2004 | 14 | 5 | 19 |
| 2005 | 15 | 3 | 18 |
| 2006 | 13 | 6 | 19 |
| 2007 | 17 | 1 | 18 |
| 2008 | 29 | 3 | 32 |
| 2009 | 18 | 2 | 20 |
| 2010 | 17 | 3 | 20 |
| 2011 | 19 | 7 | 26 |
| 2012 | 28 | 8 | 36 |
| 2013 | 30 | 4 | 34 |
| 2014 | 43 | 3 | 46 |
| 2015 | 24 | 2 | 26 |
| 2016 | 20 | 7 | 27 |
| 2017 | 29 | 2 | 31 |
| 2018 | 40 | 3 | 43 |
| 2019 | 23 | 6 | 29 |
| 2020 | 25 | 4 | 29 |
| 2021 | 39 | 0 | 39 |
| 2022 | 35 | 0 | 35 |
| 2023 | 36 | 4 | 40 |
| 2024 | 33 | 6 | 39 |
| 2025 | 2 | 3 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Colorectal Neoplasms" by people in Profiles.
-
Stress-Testing US Colorectal Cancer Screening Guidelines: Decennial Colonoscopy from Age 45 is Robust to Natural History Uncertainty and Colonoscopy Sensitivity Assumptions. Med Decis Making. 2025 Jul; 45(5):557-568.
-
Afatinib in patients with solid tumors with neuregulin 1 (NRG1) fusions: a case series from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. ESMO Open. 2025 May; 10(5):104545.
-
Minimum Requirements to Safely Establish and Sustain New Hepatic Arterial Infusion Pump Programs: An International Expert Perspective. Ann Surg Oncol. 2025 Jun; 32(6):4408-4416.
-
Genomic and cellular responses to aspirin in colonic organoids from African- and European-Americans. Physiol Genomics. 2025 Mar 01; 57(3):103-114.
-
Rethinking the rise of early-onset gastrointestinal cancers: a call to action. JNCI Cancer Spectr. 2025 Jan 03; 9(1).
-
Optimal Stopping Ages for Colorectal Cancer Screening. JAMA Netw Open. 2024 Dec 02; 7(12):e2451715.
-
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2024 12; 22(10):695-711.
-
Harmonizing data across the accelerating colorectal cancer screening and follow-up through implementation science (ACCSIS) program to enhance data quality and promote data sharing. BMC Health Serv Res. 2024 Nov 06; 24(1):1356.
-
Management of Colorectal Neoplasia in IBD Patients: Current Practice and Future Perspectives. J Crohns Colitis. 2024 Oct 15; 18(10):1726-1735.
-
5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. JCO Precis Oncol. 2024 Oct; 8:e2400277.